Catalio Capital Management, LP Quant / Systematic

Location: New York, NY

CIK: 0001958125 · Show all filings

Period: Q2 2026 (← Previous)

Filing Date: Aug 14, 2026

Total Value: $532M (100.0% shares, 0.0% debt)

Holdings (39)

AVLN AVALYN PHARMACEUTICALS INC 10.4%

Value $55.17M Shares 1,675,830 Est. Cost — Unrealized —

JNJ JOHNSON & JOHNSON 6.6%

Value $35.29M Shares 138,946 Est. Cost — Unrealized —

GILD GILEAD SCIENCES INC 6.4%

Value $34.02M Shares 269,309 Est. Cost — Unrealized —

BBIO BRIDGEBIO PHARMA INC 6.4%

Value $33.89M Shares 455,041 Est. Cost — Unrealized —

SNDX SYNDAX PHARMACEUTICALS INC 5.0%

Value $26.58M Shares 1,215,698 Est. Cost — Unrealized —

DFTX DEFINIUM THERAPEUTICS INC 5.0%

Value $26.47M Shares 562,672 Est. Cost — Unrealized —

BMY BRISTOL-MYERS SQUIBB CO 4.5%

Value $23.79M Shares 412,961 Est. Cost — Unrealized —

PBLS PARABILIS MEDICINES INC 4.2%

Value $22.55M Shares 824,043 Est. Cost — Unrealized —

NTRA NATERA INC 4.2%

Value $22.31M Shares 82,181 Est. Cost — Unrealized —

INCY INCYTE CORP 4.1%

Value $21.72M Shares 191,627 Est. Cost — Unrealized —

SEPN SEPTERNA INC 3.4%

Value $17.96M Shares 536,152 Est. Cost — Unrealized —

MLYS MINERALYS THERAPEUTICS INC 3.3%

Value $17.5M Shares 648,722 Est. Cost — Unrealized —

HTFL HEARTFLOW INC 3.2%

Value $17.11M Shares 583,055 Est. Cost — Unrealized —

CRVS CORVUS PHARMACEUTICALS INC 3.0%

Value $16.15M Shares 1,080,888 Est. Cost — Unrealized —

GPCR STRUCTURE THERAPEUTICS INC 2.8%

Value $14.84M Shares 276,550 Est. Cost — Unrealized —

PTGX PROTAGONIST THERAPEUTICS INC 2.5%

Value $13.09M Shares 106,799 Est. Cost — Unrealized —

IRON DISC MEDICINE INC 2.2%

Value $11.66M Shares 159,384 Est. Cost — Unrealized —

EW EDWARDS LIFESCIENCES CORP 2.1%

Value $11.29M Shares 124,778 Est. Cost — Unrealized —

AXSM AXSOME THERAPEUTICS INC. 2.0%

Value $10.57M Shares 43,182 Est. Cost — Unrealized —

RARE ULTRAGENYX PHARMACEUTICAL IN 2.0%

Value $10.56M Shares 316,252 Est. Cost — Unrealized —

KLRA KAILERA THERAPEUTICS INC 1.9%

Value $10.33M Shares 468,750 Est. Cost — Unrealized —

KPTI KARYOPHARM THERAPEUTICS INC 1.7%

Value $9.192M Shares 940,855 Est. Cost — Unrealized —

ODTX ODYSSEY THERAPEUTICS INC 1.6%

Value $8.566M Shares 457,839 Est. Cost — Unrealized —

ASND ASCENDIS PHARMA A/S 1.6%

Value $8.471M Shares 31,759 Est. Cost — Unrealized —

KARD KARDIGAN INC 1.4%

Value $7.453M Shares 312,500 Est. Cost — Unrealized —

ELDN ELEDON PHARMACEUTICALS INC 1.3%

Value $6.679M Shares 1,695,071 Est. Cost — Unrealized —

FDMT 4D MOLECULAR THERAPEUTICS IN 1.2%

Value $6.268M Shares 471,254 Est. Cost — Unrealized —

MANE VERADERMICS INC 1.1%

Value $5.638M Shares 45,856 Est. Cost — Unrealized —

DYN DYNE THERAPEUTICS INC 1.0%

Value $5.44M Shares 244,929 Est. Cost — Unrealized —

GUTS FRACTYL HEALTH INC 0.9%

Value $4.9M Shares 6,168,749 Est. Cost — Unrealized —

IMCR IMMUNOCORE HLDGS PLC 0.9%

Value $4.7M Shares 148,045 Est. Cost — Unrealized —

DNTH DIANTHUS THERAPEUTICS INC 0.6%

Value $3.211M Shares 32,941 Est. Cost — Unrealized —

BBOT BRIDGEBIO ONCOLOGY THERAPEUT 0.5%

Value $2.426M Shares 318,407 Est. Cost — Unrealized —

TARA PROTARA THERAPEUTICS INC 0.4%

Value $1.987M Shares 520,148 Est. Cost — Unrealized —

HYPR HYPERFINE INC 0.3%

Value $1.782M Shares 1,320,041 Est. Cost — Unrealized —

ATAI ATAIBECKLEY INC 0.2%

Value $1.037M Shares 196,858 Est. Cost — Unrealized —

MGX METAGENOMI THERAPEUTICS INC 0.1%

Value $630K Shares 528,993 Est. Cost — Unrealized —

OM OUTSET MED INC 0.1%

Value $511K Shares 118,279 Est. Cost — Unrealized —

SNSE FAETH THERAPEUTICS INC 0.1%

Value $368K Shares 14,718 Est. Cost — Unrealized —

Ticker	Issuer	Shares	Value	%	Est. Cost	Unrealized	Class	CUSIP
AVLN	AVALYN PHARMACEUTICALS INC	1,675,830	$55.17M	10.4%	—	—	COM SHS	05348Y105
JNJ	JOHNSON & JOHNSON	138,946	$35.29M	6.6%	—	—	COM	478160104
GILD	GILEAD SCIENCES INC	269,309	$34.02M	6.4%	—	—	COM	375558103
BBIO	BRIDGEBIO PHARMA INC	455,041	$33.89M	6.4%	—	—	COM	10806X102
SNDX	SYNDAX PHARMACEUTICALS INC	1,215,698	$26.58M	5.0%	—	—	COM	87164F105
DFTX	DEFINIUM THERAPEUTICS INC	562,672	$26.47M	5.0%	—	—	COM SHS	24477V105
BMY	BRISTOL-MYERS SQUIBB CO	412,961	$23.79M	4.5%	—	—	COM	110122108
PBLS	PARABILIS MEDICINES INC	824,043	$22.55M	4.2%	—	—	COM	698955101
NTRA	NATERA INC	82,181	$22.31M	4.2%	—	—	COM	632307104
INCY	INCYTE CORP	191,627	$21.72M	4.1%	—	—	COM	45337C102
SEPN	SEPTERNA INC	536,152	$17.96M	3.4%	—	—	COM	81734D104
MLYS	MINERALYS THERAPEUTICS INC	648,722	$17.5M	3.3%	—	—	COM	603170101
HTFL	HEARTFLOW INC	583,055	$17.11M	3.2%	—	—	COM	42238D107
CRVS	CORVUS PHARMACEUTICALS INC	1,080,888	$16.15M	3.0%	—	—	COM	221015100
GPCR	STRUCTURE THERAPEUTICS INC	276,550	$14.84M	2.8%	—	—	SPONSORED ADS	86366E106
PTGX	PROTAGONIST THERAPEUTICS INC	106,799	$13.09M	2.5%	—	—	COM	74366E102
IRON	DISC MEDICINE INC	159,384	$11.66M	2.2%	—	—	COM	254604101
EW	EDWARDS LIFESCIENCES CORP	124,778	$11.29M	2.1%	—	—	COM	28176E108
AXSM	AXSOME THERAPEUTICS INC.	43,182	$10.57M	2.0%	—	—	COM	05464T104
RARE	ULTRAGENYX PHARMACEUTICAL IN	316,252	$10.56M	2.0%	—	—	COM	90400D108
KLRA	KAILERA THERAPEUTICS INC	468,750	$10.33M	1.9%	—	—	COMMON STOCK	482931102
KPTI	KARYOPHARM THERAPEUTICS INC	940,855	$9.192M	1.7%	—	—	COM NEW	48576U205
ODTX	ODYSSEY THERAPEUTICS INC	457,839	$8.566M	1.6%	—	—	COMMON STOCK	67613T104
ASND	ASCENDIS PHARMA A/S	31,759	$8.471M	1.6%	—	—	ORD SHS	K08588103
KARD	KARDIGAN INC	312,500	$7.453M	1.4%	—	—	COM	485925101
ELDN	ELEDON PHARMACEUTICALS INC	1,695,071	$6.679M	1.3%	—	—	COM	28617K101
FDMT	4D MOLECULAR THERAPEUTICS IN	471,254	$6.268M	1.2%	—	—	COM	35104E100
MANE	VERADERMICS INC	45,856	$5.638M	1.1%	—	—	COMMON STOCK	922967104
DYN	DYNE THERAPEUTICS INC	244,929	$5.44M	1.0%	—	—	COM	26818M108
GUTS	FRACTYL HEALTH INC	6,168,749	$4.9M	0.9%	—	—	COM	35168W103
IMCR	IMMUNOCORE HLDGS PLC	148,045	$4.7M	0.9%	—	—	ADS	45258D105
DNTH	DIANTHUS THERAPEUTICS INC	32,941	$3.211M	0.6%	—	—	COM	252828108
BBOT	BRIDGEBIO ONCOLOGY THERAPEUT	318,407	$2.426M	0.5%	—	—	COM NEW	107924102
TARA	PROTARA THERAPEUTICS INC	520,148	$1.987M	0.4%	—	—	COM STK	74365U107
HYPR	HYPERFINE INC	1,320,041	$1.782M	0.3%	—	—	COM CL A	44916K106
ATAI	ATAIBECKLEY INC	196,858	$1.037M	0.2%	—	—	COM SHS	04650F101
MGX	METAGENOMI THERAPEUTICS INC	528,993	$630K	0.1%	—	—	COM	59102M104
OM	OUTSET MED INC	118,279	$511K	0.1%	—	—	COM NEW	690145206
SNSE	FAETH THERAPEUTICS INC	14,718	$368K	0.1%	—	—	COM NEW	81728A207